en

PRODUCT DETAIL

Uplizna 100 mg koncentrát na infúzny roztok

Code 1095E
MA number EU/1/21/1602/001
Product Form: con inf 3x10 ml/100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA47 Inebilizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 25.04.2022
Validity: 25.04.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.05.2022
eu-flag.png sk-flag.png